2025
Shafrin J, Wang S, Sharma K, Spurrier K, Nordyke RJ . 2025. Will the Institute for Clinical and Economic Review’s shared savings approach decrease value-based prices most for the most severe diseases? Value Health 28(1):25-30; doi: 10.1016/j.val.2024.09.002 . PMID: 39357669.
View Abstract
Topics: Health Economics and Outcomes Research (HEOR)
Patterson JA, Motyka J, Salih R, Nordyke RJ , O’Brien JM, Campbell JD. 2025. Subsequent indications in oncology drugs: Pathways, timelines, and the Inflation Reduction Act. Ther Innov Regul Sci 59(1):102-111; doi: 10.1007/s43441-024-00706-6 . PMID: 39369117.
View Abstract
Topics: drug development
Lipworth L, Panko JM, Allen BC, Mumma MT, Jiang X , Vincent MJ, Bare JL, Antonijevic T, Vivanco SN, Marano DE, Suh M , Cohen S, Mittal L, Proctor DM. 2025. Lung cancer mortality among aircraft manufacturing workers with long-term, low-level, hexavalent chromium exposure. J Occup Environ Hyg 22(3):214-227 ; doi: 10.1080/15459624.2024.2439817 . PMID: 39773194.
View Abstract
Topics: Cancer , chromium , Exposure Assessment , Occupational
2024
Kim A, Cong Z, Jazieh A-R, Church TR, Reichert H , Nicholson G, Fryzek J, Cohen SS. 2024. Estimating the incremental population health impact of a multi-cancer early detection (MCED) test to complement existing screening among elevated risk populations with multiple cancer risk factors: A mathematical modeling study. BMC Health Serv Res 24(1):1584; doi: 10.1186/s12913-024-12037-1 . PMID: 39695574.
View Abstract
Topics: Cancer , Epidemiology
Seo S, Healey BE, McLin R, Sacks NC , Benson CJ, Citrome L. 2024. Impact of demographics and insurance coverage on schizophrenia treatment and healthcare resource utilization within an integrated healthcare system. Neuropsychiatr Dis Treat 20(Sept 26):1837–1848; doi: 10.2147/NDT.S473492 . PMID: 39351585.
View Abstract
Topics: Health Economics and Outcomes Research (HEOR)
DiBiase JF, Scharnetzki E, Edelman E, Reed EK, Helbig P, Rueter J, Miesfeldt S, Frankenfeld CL , et al. 2024. Socioeconomic and urban-rural disparities in genome-matched treatment receipt and survival after genomic tumor testing. JNCI Cancer Spectr 8(5):pkae090; doi: 10.1093/jncics/pkae090 . PMID: 39312685.
View Abstract
Topics: Cancer , Epidemiology , Health Economics and Outcomes Research (HEOR)
Bean K, Jones SA, Chakrapani A, Vijay S, Wu T, Church H, … Jensen I , et al. 2024. Exploring the cost-effectiveness of newborn screening for metachromatic leukodystrophy (MLD) in the UK. Int J Neonatal Screen 10(3):45; doi: 10.3390/ijns10030045 .
View Abstract
Topics: Health Economics and Outcomes Research (HEOR) , Metachromatic leukodystrophy (MLD)
Chew DS, Sacks NC , Emden MR, Cyr PL , Sherwood R, Pokorney SD. 2024. Catheter ablation for supraventricular tachycardia and health resource utilization and expenditures: A propensity-matched cohort study. Int J Cardiol 403(May 15):131831; doi: 10.1016/j.ijcard.2024.131831 . PMID: 38331201.
View Abstract
Topics: Health Economics and Outcomes Research (HEOR)
Bonkowsky J, Healey B, Sacks NC , McLin R, Cyr PL , Sawyer EK, Stephen CD, et al. 2024. Burden of illness and mortality in men with adrenomyeloneuropathy: A retrospective cohort study. Orph J Rare Dis 19(1):270; doi: 10.1186/s13023-024-0326-w . PMID: 39020416.
View Abstract
Topics: Epidemiology , Health Economics and Outcomes Research (HEOR)
Wharton GT, Becker C, Bennett D, Burcu M, Bushnell G, Ferrajolo C,… Movva N ,…, Suh M , et al. 2024. Overview of global real-world data sources for pediatric pharmacoepidemiologic research. Pharmacoepidemiol Drug Saf 33(1):e5695; doi: 10.1002/pds.5695 . PMID: 37690792.
View Abstract
A Division of